AbbVie: Double-Digit Growth For Immunology Products Continues With HUMIRA Surprise

Core Insights - The article highlights the offerings of Biotech Analysis Central, a service focused on deep-dive analysis of pharmaceutical companies, providing valuable insights for investors in the biotech sector [1][2]. Group 1: Company Overview - Biotech Analysis Central is led by Terry Chrisomalis, who has extensive experience in the biotech sector and aims to generate long-term value from healthcare investments [2]. - The service includes a library of over 600 biotech investing articles and a model portfolio featuring more than 10 small and mid-cap stocks, each with in-depth analysis [2]. Group 2: Subscription Details - The subscription to Biotech Analysis Central is priced at $49 per month, with a promotional offer of a 33.50% discount for annual subscriptions, bringing the yearly cost to $399 [1].